CClinicalTrials.gg
CompletedNCT04419662Updated Aug 6, 2021

Evaluation of Patients After Cardiac Surgery: Novel Ultrasound Parameters for Quantification of Renal Perfusion & Analysis of Phenylephrines' Effect on Invasive Haemodynamics and Echocardiographic Measures

A Phase 4 interventional study of Phenylephrine and Combination of PEEP and positioning in Ultrasonography, Renal, Cardiac Surgery and Hemodynamics, sponsored by Aarhus University Hospital. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-08-06.

Sponsored by Aarhus University Hospital · Phase 4, Interventional, and Diagnostic

Phase
Phase 4
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

To investigate the influence of PEEP (Positive end-expiratory pressure), changes in preload (patient position) and changes in afterload (phenylephrine) on ultrasound measures of renal perfusion in patients after uncomplicated cardiac surgery.

To investigate the effects of phenylephrine on both invasive measures of the systemic- and pulmonary circulation and, secondarily, to assess the induced changes in echocardiographic indices of left- and right ventricular systolic- and diastolic function.

02

Conditions studied

  • Ultrasonography, Renal
  • Cardiac Surgery
  • Hemodynamics
  • Phenylephrine
  • Renal Perfusion
  • Echocardiography
  • Anesthesia
03

In context

Lead sponsor

Aarhus University Hospital is the lead sponsor of 289 studies on the registry; 79 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All patients ≥ 18 years scheduled for open elective cardiac surgery at the Department of Cardiothoracic \& Vascular Surgery, Aarhus University Hospital.

Exclusion criteria

Exclusion Criteria:

  • Insufficient ultrasonographic imaging of the kidneys
  • Known morphological kidney disease
  • Preoperative dialysis
  • Chronic atrial fibrillation
  • Planned mitral valve surgery
05

Study design

Phase
Phase 4
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    All patients included

    Drug: Phenylephrine · Other: Combination of PEEP and positioning

Interventions

  • DrugPhenylephrine

    Three time points: before, during and 20-30 minutes after infusion of phenylephrine. Patients will receive an infusion of up to 1 mcg/kg/min phenylephrine intravenously to raise mean arterial pressure with 20 mmHg for 10 minutes. Infusion of phenylephrine will start at 0.1 mcg/kg/min with subsequent titration to effect.

  • OtherCombination of PEEP and positioning

    Six time points based on combinations of the following: Three different levels of PEEP (as set on the ventilator): 0, 6 and 12 mmHg. Two different positions: 1) torso elevated 30 degrees, legs horizontal and 2) torso horizontal, legs elevated 30 degrees.

06

What researchers measure

Primary outcomes

  1. Renal arterial resistive index (RI).

    Time frame: 75 minutes

  2. The ratio SVR/PVR (systemic vascular resistance/pulmonary vascular resistance)

    Time frame: 75 minutes

Secondary outcomes

  1. Renal venous impedance index.

    Time frame: 75 minutes

  2. Renal venous stasis index.

    Time frame: 75 minutes

  3. Portal vein pulsatility fraction.

    Time frame: 75 minutes

  4. Cardiac output

    Time frame: 75 minutes

  5. Arterial blood pressure, central venous pressure, pulmonary blood pressure, pulmonary capillary wedge pressure.

    Time frame: 75 minutes

  6. Transoesophageal measurement of left and right ventricular function 1

    Systolic measure (ejection fraction (EF))

    Time frame: 75 minutes

  7. Transoesophageal measurement of left and right ventricular function 2

    Systolic measure (s')

    Time frame: 75 minutes

  8. Transoesophageal measurement of left and right ventricular function 3

    Systolic measure (strain)

    Time frame: 75 minutes

  9. Transoesophageal measurement of left and right ventricular function 4

    Diastolic measures (E, A,)

    Time frame: 75 minutes

  10. Transoesophageal measurement of left and right ventricular function 5

    Diastolic measures (e', a')

    Time frame: 75 minutes

  11. Transoesophageal measurement of left and right ventricular function 6

    Diastolic measure (deceleration time)

    Time frame: 75 minutes

07

Study locations

1 site
  • Aarhus University Hospital, Department of Anaesthesiology
    Aarhus, 8200, Denmark
08

References and documents

Publications

  • Hermansen JL, Norskov J, Juhl-Olsen P. Effects of changes in position, positive end-expiratory pressure and mean arterial pressure on renal, portal and hepatic Doppler ultrasound perfusion indices: a randomized crossover study in cardiac surgery patients. J Clin Monit Comput. 2022 Dec;36(6):1841-1850. doi: 10.1007/s10877-022-00834-0. Epub 2022 Mar 1. PubMed 35230558 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04419662
Lead sponsor
Aarhus University Hospital
Responsible party
Johan Fridolf Hermansen (Principal Investigator, Aarhus University Hospital) — Principal investigator
First posted
Jun 5, 2020
Start date
May 25, 2020
Primary completion
May 30, 2021
Completion
May 31, 2021
Last update
Aug 6, 2021

Study contacts

Peter Juhl-Olsen, MD, PhD
study chair · Aarhus University Hospital
Johan F Hermansen, MD
principal investigator · Aarhus University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion